OneOncology Finalizes 25 Oncology and Hematology Pathways
NASHVILLE, Tenn., Aug. 28, 2023 /PRNewswire/ -- OneOncology, the fastest-growing national platform for independent practices, announced today it has finalized 25 unique oncology and hematology pathways and published each pathway inside the platform's clinical decision support tool.
- NASHVILLE, Tenn., Aug. 28, 2023 /PRNewswire/ -- OneOncology, the fastest-growing national platform for independent practices, announced today it has finalized 25 unique oncology and hematology pathways and published each pathway inside the platform's clinical decision support tool.
- Edward Arrowsmith, MD, Medical Director of OneOncology's Pathways Program, and experts from its five disease groups, (gastrointestinal, genitourinary, breast, lung, and hematology) and disease subject matter experts (gynecology, head, and neck) lead in authoring OneOncology pathways.
- "Our cancer patient population is very diverse, and therefore, pathways must account for the numerous clinical scenarios that can present in each cancer type," said Davey Daniel, MD, OneOncology CMO.
- "Efficacy and safety are the first priorities of our Pathways Program," said Lisa Raff, OneOncology Vice President, Pharmacy Services.